QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING
The questions and answers below highlight only selected information from this Proxy Statement and only briefly address some commonly asked questions about the Special Meeting and the Proposals. The following questions and answers do not include all the information that is important to the Company’s stockholders. Stockholders are urged to read carefully this entire Proxy Statement, including Annex A, Annex B, Annex C and the other documents referred to herein, to fully understand the Proposals and the voting procedures for the Special Meeting.
Q:
Why am I receiving this Proxy Statement?
A:
We are a blank check company incorporated as a Delaware corporation and formed for the purpose of effecting a merger, consolidation, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. On July 13, 2021, we consummated our IPO of 30,000,000 units (the “units”), each consisting of one share of Class A common stock and one-third of one redeemable warrant (the “public warrants”). The units were sold at an offering price of $10.00 per unit, generating gross proceeds of $300,000,000. Concurrently with the completion of the IPO, we consummated the private placement of an aggregate of 5,235,000 warrants (the “private placement warrants”), each exercisable to purchase one share of our Class A common stock for $11.50 per share, subject to certain adjustments, to our Sponsor at a price of $1.50 per private placement warrant, generating total proceeds of $7,852,500.
On August 3, 2021, as part of the IPO, we consummated the sale of 4,500,000 units (the “over-allotment units”) pursuant to the underwriters’ full exercise of their over-allotment option (the “over-allotment”) granted in connection with the IPO. Such over-allotment units were sold at $10.00 per unit, generating gross proceeds of $45,000,000. Substantially concurrently with the sale of the over-allotment, we consummated the private placement of an additional 600,000 private placement warrants to our Sponsor at a price of $1.50 per private placement warrant, generating total proceeds of $900,000.
Of the gross proceeds received from the IPO, the over-allotment and the sale of private placement warrants, $345,000,000 was placed in the Trust Account.
Like most blank check companies, the Certificate of Incorporation provides for the return of the funds held in Trust Account to our public stockholders if we do not consummate an initial business combination within 24 months from the closing of the IPO, or 27 months from the closing of the IPO if we have executed a letter of intent, agreement in principle or definitive agreement for our initial business combination within such 24-month period. Without the Extension, if we are unable to enter into and consummate an initial business combination on or before July 13, 2023 (or October 13, 2023, if we have executed a letter of intent, agreement in principle or definitive agreement for an initial business combination by July 13, 2023), we would be precluded from completing our initial business combination and would be forced to liquidate. Our board currently believes that it is unlikely that we will be able to negotiate and complete our initial business combination before July 13, 2023. Accordingly, our board believes that in order for us to potentially consummate an initial business combination, we will need to obtain the Extension.
Our board has determined that it is in the best interests of the Company and our stockholders to amend the Certificate of Incorporation to extend the date we have to consummate an initial business combination to July 13, 2024, in order to allow us and our board to evaluate, negotiate and enter into an initial business combination, and subsequently to allow our stockholders to evaluate the initial business combination, and for us to be able to potentially consummate an initial business combination, and is submitting the Proposals to our stockholders to vote upon at the Special Meeting. Our board has also determined that it is in the best interests of the Company and our stockholders to provide our board with additional flexibility to consummate an Early Liquidation if a suitable initial business combination does not emerge despite the Extension or if our board otherwise determines that such action would be in the best interests of the Company and our stockholders.
Q:
What are the specific Proposals on which I am being asked to vote at the Special Meeting?
A:
Our stockholders are being asked to consider and vote on the following Proposals:
•
Proposal No. 1 — The Extension Amendment Proposal — to amend the Company’s Certificate of Incorporation, in the form set forth in Annex A to this Proxy Statement, to extend the date by which